Meet the AION TempShield™

“The TempShield is to cancer patients like the glucose monitor is to diabetics. We have seen that the Tempshield is the difference between an antibiotic and a hospitalization.”

Dr. Tallat Mahmood
Medical Director at Roswell Park Cancer, Ellis Medicine

Meet the AION TempShield™

“The TempShield is to cancer patients like the glucose monitor is to diabetics. We have seen that the Tempshield is the difference between an antibiotic and a hospitalization.”

Dr. Tallat Mahmood
Medical Director at Roswell Park Cancer, Ellis Medicine

Advancing Early Infection Detection

AION TempShield™ is improving outcomes by detecting infections early. Hear from patients and the Director of Medical Oncology at Roswell Park Cancer Center, Ellis Medicine.

Features of the AION TempShield™

  • FDA Clearance

    FDA-cleared Class II medical device.

  • Continuous Body Temperature Monitoring

    24/7 Real-Time Tracking.

  • Long Battery Life

    Up to 90 days of usage per charge.

  • Cost-Effective & Reimbursable

    Low cost, reimbursable under CMS code 99454.

  • Advanced Connectivity

    Bluetooth compatibility, mobile app integration, and seamless EMR (Electronic Medical Record) integration.

  • Clinician Tools

    Dedicated dashboard for healthcare providers.

  • Comfortable Design

    Unparalleled comfort with a low-profile form factor.

Interested in learning about an AION Biosystems™ demo program?

Earlier Detection of Infection is Critical

  • Allows for timely initiation of appropriate treatment
  • Reduces the risk of complications, hospitalizations, or long-term health consequences associated with untreated or inadequetly treated infections
  • Can result in cost savings for both patients and healthcare systems

Who can benefit?

Cancer
Post Operation
Sepsis
Pediatrics
Long-Term Care

News

AI in Healthcare Podcast

“How Wearables Are Transforming Cancer Care”
Sam Barend, CEO of AION Biosystems, joins oncology thought leaders Dr. Doug Flora, Dr. Sanjay Juneja, and Dr. David Penberthy to discuss how TempShield is redefining the standard of care through early, proactive complication detection.

  • 2025/12/11

    How Wearables Are Transforming Oncology Care

  • 2025/08/29

    Florida Invests $2M Dollars in TempShield to Cut Infection Deaths in Chemo Patients

  • 2025/06/10

    How AI Is Helping Cancer Patients: Saving Lives And Money